Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Study of Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma

NCT04996459 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04996459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04996459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Study of Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma
Lead sponsor
Fudan University
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2020
Completion date
June 30, 2022
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma